Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function

BACKGROUND: Direct-acing antiviral agents are highly efficient treatment options for chronic hepatitis C virus (HCV) infection after renal allograft transplantation. Treatment options for patients with impaired graft function remain limited. Therefore, we assessed the effectiveness and safety of gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenberger, Ute, Friebus-Kardash, Justa, Guberina, Hana, Kribben, Andreas, Witzke, Oliver, Willuweit, Katharina, Gerken, Guido, Herzer, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324915/
https://www.ncbi.nlm.nih.gov/pubmed/30656217
http://dx.doi.org/10.1097/TXD.0000000000000860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324915/
https://www.ncbi.nlm.nih.gov/pubmed/30656217
http://dx.doi.org/10.1097/TXD.0000000000000860

Ejemplares similares